Isoniazid is one of the most effective antituberculosis drugs, yet its precise mechanism of action is still controversial. Using specialized linkage transduction, a single point mutation allele (S94A) within the putative target gene inhA was transferred in Mycobacterium tuberculosis. The inhA(S94A) allele was sufficient to confer clinically relevant levels of resistance to isoniazid killing and inhibition of mycolic acid biosynthesis. This resistance correlated with the decreased binding of the INH-NAD inhibitor to InhA, as shown by enzymatic and X-ray crystallographic analyses, and establishes InhA as the primary target of isoniazid action in M. tuberculosis.
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Publishing Authors By Initials
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Journal Published:
PUBLICATION TYPE: Research Support, Non-U.S. Gov
Journal: Nature medicine
VOLUME: 12
Page Numbers: 1027-9
Journal Abbreviation:
ISSN: 1078-8956
DAY: 13
MONTH: 08
YEAR: 2006
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9502015
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
AFFILIATION: Howard Hughes Medical Institute, Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Nat Med
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid Related Publications